Of the dozens of vaccines in late-stage trials, the next data release will likely be from AstraZeneca Plc by Christmas. Coronavirus (Covid-19) vaccine latest updatesPfizer-BioNTech coronavirus vaccineSuccess rate: Taking the lead in the global chase for a Covid-19 antidote, Pfizer Inc said on Wednesday that final results from the late-stage trial of its Covid-19 vaccine, developed with German partner BioNTech SE, show it was 95 per cent effective. Effectiveness: Pfizer stated that the vaccine’s efficacy was found to be consistent across different ages and ethnicities. Effectiveness: In older adults, the Moderna vaccine produced virus-neutralising antibodies at levels similar to those seen in younger adults, according to a study, published in the New England Journal of Medicine. More specifically, Oxford said it would start initial analysis of data from its late-stage trials after 53 infections among its volunteers.

Source: Indian Express November 20, 2020 08:56 UTC